NCT02183181View on ClinicalTrials.gov

Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2009

Conditions
Healthy
Interventions
DRUG

Meloxicam capsule

DRUG

Meloxicam tablet

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY